Cat. No.: OCKT-2603-CXX-021
Description: This product can be used to efficiently construct the human lung adenocarcinoma organoid. Comprising basal medium A and two concentrated supplements, this set is engineered for the high-efficiency development of human lung adenocarcinoma organoids.
Price: Inquiry
Datasheet: Datasheet
| Size | 100 mL/500 mL |
| Advantages | Organoids derived from lung adenocarcinoma accurately replicate the tumor's microenvironment, allowing researchers to observe cellular behaviors. They serve as an in vitro platform to track drug-induced changes in tumor cells and to screen for therapeutic efficacy and potential toxicity. |
| Species | Human |
| Components | Basal Medium A; Supplement B & Supplement C. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Basal Medium A: 4°C, 1 year; Supplement B & Supplement C: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Supplement B & Supplement C: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.
